The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes
A Scoping Review
Published in: The Milbank Quarterly, Volume 98, Number 1, pages 57–105 (March 2020). doi: 10.1111/1468-0009.12436
Posted on RAND.org on April 29, 2020
- This scoping review reveals a growing literature on the effects of certain state opioid misuse prevention policies, but persistent gaps in evidence on other prevalent state policies remain.
- Policymakers interested in reducing the volume and dosage of opioids prescribed and dispensed can consider adopting robust prescription drug monitoring programs with mandatory access provisions and drug supply management policies, such as prior authorization policies for high-risk prescription opioids.
- Further research should concentrate on potential unintended consequences of opioid misuse prevention policies, differential policy effects across populations, interventions that have not received sufficient evaluation (eg, Good Samaritan laws, naloxone access laws), and patient-related outcomes.